Ethos Financial Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.1M Buy
11,831
+1,389
+13% +$324K 0.21% 101
2026
Q1
$2.44M Buy
10,442
+65
+0.6% +$15.1K 0.18% 122
2025
Q4
$2.15M Buy
10,377
+1,267
+14% +$251K 0.16% 131
2025
Q3
$1.69M Buy
9,110
+53
+0.6% +$9.08K 0.13% 137
2025
Q2
$1.38M Sell
9,057
-8,927
-50% -$1.37M 0.12% 147
2025
Q1
$2.74M Buy
17,984
+12,245
+213% +$1.92M 0.26% 91
2024
Q4
$832K Buy
5,739
+193
+3% +$29.9K 0.11% 114
2024
Q3
$899K Sell
5,546
-821
-13% -$131K 0.15% 86
2024
Q2
$957K Buy
6,367
+372
+6% +$55.3K 0.17% 79
2024
Q1
$948K Sell
5,995
-47
-0.8% -$7.48K 0.18% 80
2023
Q4
$947K Sell
6,042
-2,692
-31% -$413K 0.2% 77
2023
Q3
$1.36M Buy
8,734
+234
+3% +$38.6K 0.35% 49
2023
Q2
$1.32M Hold
8,500
0.45% 41
2023
Q1
$1.32M Buy
8,500
+306
+4% +$49.4K 0.41% 44
2022
Q4
$1.45M Buy
+8,194
New +$1.41M 0.49% 39

Other funds holding JNJ

Ethos Financial Group's JNJ Position: Q2 2026 in Review

Ethos Financial Group increased its Johnson & Johnson (JNJ) stake by 13% in Q2 2026, buying an estimated $324K and bringing the position to 11,831 shares worth $3.1M. The position accounts for 0.21% of the portfolio, ranked #101.

Ethos Financial Group first reported a position in JNJ in Q4 2022 and has held it in 15 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Ethos Financial Group held 11,831 shares of Johnson & Johnson worth $3.1M as of Q2 2026.
  • Ethos Financial Group bought 1,389 Johnson & Johnson shares in Q2 2026, an estimated $324K.
  • Johnson & Johnson made up 0.21% of Ethos Financial Group's portfolio in Q2 2026, its #101 holding.
  • Ethos Financial Group first reported a position in Johnson & Johnson in Q4 2022 and has held it in 15 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Ethos Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.